Schonfeld Strategic Advisors LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2024$5,651,269
+25.3%
359,267
+28.5%
0.04%
+26.7%
Q4 2023$4,508,512
+52.2%
279,511
+20.0%
0.03%
+30.4%
Q3 2023$2,962,488
-7.3%
232,900
+2.6%
0.02%
-14.8%
Q2 2023$3,195,498
-16.3%
226,953
-8.2%
0.03%
-27.0%
Q1 2023$3,819,827
+20.3%
247,238
+27.6%
0.04%
+42.3%
Q4 2022$3,175,825
+0.3%
193,766
+13.2%
0.03%
-3.7%
Q3 2022$3,167,000
+2084.1%
171,137
+1048.6%
0.03%
+2600.0%
Q4 2021$145,000
-95.5%
14,900
-84.3%
0.00%
-97.0%
Q3 2021$3,223,000
+128.7%
94,840
+146.5%
0.03%
+120.0%
Q2 2021$1,409,000
+16.0%
38,471
+42.0%
0.02%0.0%
Q1 2021$1,215,000
-33.1%
27,096
-14.9%
0.02%
-37.5%
Q4 2020$1,817,000
+7.7%
31,823
-3.3%
0.02%
-25.0%
Q3 2020$1,687,000
-31.6%
32,900
-20.4%
0.03%
-3.0%
Q2 2020$2,468,000
+35.0%
41,318
+40.7%
0.03%
-26.7%
Q4 2019$1,828,000
+202.6%
29,371
-2.6%
0.04%0.0%
Q1 2018$604,000
+77.6%
30,146
+101.0%
0.04%
+60.7%
Q4 2017$340,000
-64.2%
15,000
-70.0%
0.03%
-67.8%
Q3 2017$950,00050,0000.09%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$19,824,86914.35%
Redmile Group, LLC 3,593,317$58,894,4662.41%
BRAIDWELL LP 3,271,513$53,620,0981.80%
Parkman Healthcare Partners LLC 344,920$5,653,2391.50%
ARMISTICE CAPITAL, LLC 5,172,000$84,769,0801.48%
Ikarian Capital, LLC 367,119$6,017,0811.45%
Sunesis Advisors, LLC 96,299$1,578,3411.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,228$38,503,8470.80%
Hillsdale Investment Management Inc. 328,200$5,379,1980.46%
Avidity Partners Management LP 1,126,000$18,455,1400.40%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders